Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 19158292)

1.

Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo.

Beirowski B, Babetto E, Gilley J, Mazzola F, Conforti L, Janeckova L, Magni G, Ribchester RR, Coleman MP.

J Neurosci. 2009 Jan 21;29(3):653-68. doi: 10.1523/JNEUROSCI.3814-08.2009.

2.

Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo.

Babetto E, Beirowski B, Janeckova L, Brown R, Gilley J, Thomson D, Ribchester RR, Coleman MP.

J Neurosci. 2010 Oct 6;30(40):13291-304. doi: 10.1523/JNEUROSCI.1189-10.2010.

3.

Axonal and neuromuscular synaptic phenotypes in Wld(S), SOD1(G93A) and ostes mutant mice identified by fiber-optic confocal microendoscopy.

Wong F, Fan L, Wells S, Hartley R, Mackenzie FE, Oyebode O, Brown R, Thomson D, Coleman MP, Blanco G, Ribchester RR.

Mol Cell Neurosci. 2009 Dec;42(4):296-307. doi: 10.1016/j.mcn.2009.08.002. Epub 2009 Aug 14.

PMID:
19683573
4.

Differential protection of neuromuscular sensory and motor axons and their endings in Wld(S) mutant mice.

Oyebode OR, Hartley R, Singhota J, Thomson D, Ribchester RR.

Neuroscience. 2012 Jan 3;200:142-58. doi: 10.1016/j.neuroscience.2011.10.020. Epub 2011 Oct 20.

PMID:
22062136
5.

A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses.

Adalbert R, Gillingwater TH, Haley JE, Bridge K, Beirowski B, Berek L, Wagner D, Grumme D, Thomson D, Celik A, Addicks K, Ribchester RR, Coleman MP.

Eur J Neurosci. 2005 Jan;21(1):271-7.

PMID:
15654865
6.

The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.

Mi W, Beirowski B, Gillingwater TH, Adalbert R, Wagner D, Grumme D, Osaka H, Conforti L, Arnhold S, Addicks K, Wada K, Ribchester RR, Coleman MP.

Brain. 2005 Feb;128(Pt 2):405-16. Epub 2005 Jan 11.

7.

WldS prevents axon degeneration through increased mitochondrial flux and enhanced mitochondrial Ca2+ buffering.

Avery MA, Rooney TM, Pandya JD, Wishart TM, Gillingwater TH, Geddes JW, Sullivan PG, Freeman MR.

Curr Biol. 2012 Apr 10;22(7):596-600. doi: 10.1016/j.cub.2012.02.043. Epub 2012 Mar 15.

8.

Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.

Kitay BM, McCormack R, Wang Y, Tsoulfas P, Zhai RG.

Hum Mol Genet. 2013 Apr 15;22(8):1601-14. doi: 10.1093/hmg/ddt009. Epub 2013 Jan 11.

9.

Intra-axonal calcium changes after axotomy in wild-type and slow Wallerian degeneration axons.

Adalbert R, Morreale G, Paizs M, Conforti L, Walker SA, Roderick HL, Bootman MD, Siklós L, Coleman MP.

Neuroscience. 2012 Dec 6;225:44-54. doi: 10.1016/j.neuroscience.2012.08.056. Epub 2012 Sep 7.

PMID:
22960623
10.

Maintaining energy homeostasis is an essential component of Wld(S)-mediated axon protection.

Shen H, Hyrc KL, Goldberg MP.

Neurobiol Dis. 2013 Nov;59:69-79. doi: 10.1016/j.nbd.2013.07.007. Epub 2013 Jul 24.

11.

Mechanisms of axonal spheroid formation in central nervous system Wallerian degeneration.

Beirowski B, Nógrádi A, Babetto E, Garcia-Alias G, Coleman MP.

J Neuropathol Exp Neurol. 2010 May;69(5):455-72. doi: 10.1097/NEN.0b013e3181da84db.

PMID:
20418780
12.

Axotomy-dependent and -independent synapse elimination in organ cultures of Wld(s) mutant mouse skeletal muscle.

Parson SH, Ribchester RR, Davie N, Gandhi NP, Malik RQ, Gillingwater TH, Thomson D.

J Neurosci Res. 2004 Apr 1;76(1):64-75.

PMID:
15048930
13.

The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model.

Beirowski B, Babetto E, Coleman MP, Martin KR.

Eur J Neurosci. 2008 Sep;28(6):1166-79. doi: 10.1111/j.1460-9568.2008.06426.x. Epub 2008 Sep 9.

PMID:
18783366
14.

WldS can delay Wallerian degeneration in mice when interaction with valosin-containing protein is weakened.

Beirowski B, Morreale G, Conforti L, Mazzola F, Di Stefano M, Wilbrey A, Babetto E, Janeckova L, Magni G, Coleman MP.

Neuroscience. 2010 Mar 10;166(1):201-11. doi: 10.1016/j.neuroscience.2009.12.024. Epub 2009 Dec 16.

PMID:
20018231
15.

NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration.

Conforti L, Fang G, Beirowski B, Wang MS, Sorci L, Asress S, Adalbert R, Silva A, Bridge K, Huang XP, Magni G, Glass JD, Coleman MP.

Cell Death Differ. 2007 Jan;14(1):116-27. Epub 2006 Apr 28.

16.

Age-dependent synapse withdrawal at axotomised neuromuscular junctions in Wld(s) mutant and Ube4b/Nmnat transgenic mice.

Gillingwater TH, Thomson D, Mack TG, Soffin EM, Mattison RJ, Coleman MP, Ribchester RR.

J Physiol. 2002 Sep 15;543(Pt 3):739-55.

17.

Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene.

Wishart TM, Paterson JM, Short DM, Meredith S, Robertson KA, Sutherland C, Cousin MA, Dutia MB, Gillingwater TH.

Mol Cell Proteomics. 2007 Aug;6(8):1318-30. Epub 2007 Apr 29.

18.

Degeneration of neuronal cell bodies following axonal injury in Wld(S) mice.

Wang AL, Yuan M, Neufeld AH.

J Neurosci Res. 2006 Dec;84(8):1799-807.

PMID:
17022038
19.

Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene.

Mack TG, Reiner M, Beirowski B, Mi W, Emanuelli M, Wagner D, Thomson D, Gillingwater T, Court F, Conforti L, Fernando FS, Tarlton A, Andressen C, Addicks K, Magni G, Ribchester RR, Perry VH, Coleman MP.

Nat Neurosci. 2001 Dec;4(12):1199-206.

PMID:
11770485
20.

The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease.

Vande Velde C, Garcia ML, Yin X, Trapp BD, Cleveland DW.

Neuromolecular Med. 2004;5(3):193-203.

PMID:
15626820
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk